Marc Lievens

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 533 citations · Full text

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E. Neafsey, Michal Juraska, Trevor Bedford et al. · New England Journal of Medicine · 2015 · 437 citations · Full text

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

Ally Olotu, Greg Fegan, Juliana Wambua et al. · New England Journal of Medicine · 2016 · 414 citations · Full text

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

Philip Bejon, John Lusingu, Ally Olotu et al. · New England Journal of Medicine · 2008 · 412 citations · Full text

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Pedro L. Alonso, Jahit Sacarlal, John J. Aponte et al. · The Lancet · 2005 · 410 citations

Vaccination, Plasmodium Falciparum Disease, Global Health +4